Ntsiki Mazwai Reacts to Possibility of Covid19 Vaccine Being Made Compulsory
- Ntsiki Mazwai has shared her thoughts about the Covid-19 vaccine
- Reports have suggested that some employers could make it mandatory for employees to vaccinate
- Miss Mazwai expressed her displeasure at these claims
PAY ATTENTION: Join Briefly News' Telegram channel! Never miss important updates!
Ntsiki Mazwai has expressed her displeasure over the possibility of some workplaces making the Covid-19 vaccine compulsory.
The poet took to social media to share her thoughts on the new developments.
She said:
“Iqala kanje. (It starts like this.)"
Social media users weighed in with their thoughts on the matter. Twitter user Mezzoseptember said:
“I knew not to trust the president when he promised that no one would be forced to take the vaccine. He also promised to watch the PPE funds with “hawk's eyes”."
According2Lowi said:
“Even travelling so if you work abroad consult with your sponsors just to be sure. Kunzima guys.”
Men_mzansi said:
“The whole point of government making the announcement earlier was to tell us that they won't take the responsibility, someone else will.”
Dlozee1 said:
“It won't be the first time, its in our labour law. Dismissal due to incapacity. But if you don't want to take the vaccine but still do come to work there is no way to be dismissed. Buy if you get sick you can be of boarded.”
Clydesithole said:
“But the president said nobody is forced to take it... And nou???”
Source: Twitter
Meanwhile, Briefly.co.za previously reported that the South African Health Department has temporarily stopped the rollout of the Oxford/AstraZeneca vaccine. The vaccine rollout was stopped after a new study showed that the vaccine was not very effective against the 501Y.V2 Covid-19 variant.
Health Minister Dr Zweli Mkhize announced on Sunday evening that a team of experts would soon give guidance on the Oxford/AstraZeneca vaccine. Mkhize was part of a panel of experts that hosted a media briefing which outlined new developments in SA's vaccine rollout.
Professor Salim Abdool Karim, one of South Africa’s leading Covid-19 experts, said the new research about the vaccine does not spell “doom and gloom”.
A report by EWN confirmed that local clinical trial data from the vaccine study for the Oxford/AstraZeneca revealed that it had a mere 22% efficacy against the 501Y.V2 Covid-19 variant dominating the country.
CNN reported that Dr Mkhize said that SA would move forward with the Pfizer/BioNtech and Johnson & Johnson vaccines. BBC stated the new study was not yet peer-reviewed and involved about 2 000 people who were on average around 31 years old.
At the beginning of the month, Briefly.co.za reported that President Cyril Ramaphosa received the first consignment of the Oxford/AstraZeneca vaccine. Deputy President David Mabuza accompanied Ramaphosa at OR Tambo International Airport.
The first one million doses of the Oxford/AstraZeneca vaccine had arrived from India. News24, at the time, reported that the vaccine doses wpould be stored and tested before mass rollout through Biovac and other distributors.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!
Source: Briefly News
